New molecular portrait of KRAS in pancreatic cancer may guide better treatments

Researchers at UNC Lineberger Comprehensive Cancer Center and colleagues have established the most comprehensive molecular portrait of the workings of KRAS, a key cancer-causing gene or "oncogene," and how its activities impact pancreatic cancer outcomes.

Related Keywords

United States ,Sarah Graham Kenan ,Lineberger Channing ,School Of Medicine Department Pharmacology ,Lineberger Comprehensive Cancer Center ,University Of North Carolina Health Care ,North Carolina Health ,Comprehensive Cancer Center ,Sarah Graham Kenan Distinguished Professor ,